Case File
efta-efta00679914DOJ Data Set 9OtherFrom: Melanie Spinella
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00679914
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Melanie Spinella
To: 'jeffrey E.' <[email protected]>
Subject: RE: To Do
Date: Thu, 03 Sep 2015 17:04:59 +0000
I read your email to Leon and he said "Tell Jeffrey he has carte blanche"
From: Jeffrey E. [mailto:[email protected]
Sent: Thursday, September 03, 2015 12:23 PM
To: Melanie Spinella
Subject: Fwd: To Do
jpm
Forwarded message
From: Barrett, Paul S
Date: Thu, Sep 3, 2015 at 8:48 AM
Subject: To Do
To: "Jeffrey Epstein ([email protected])" <[email protected]>
Cc: Barrett Team <I
Jeffrey
I am still waiting on the Balance Sheet so we can get the ISDA done. KRW still weakening. Asia FX should
continue to weaken.
But LB should do $2MM in a SP500 Market Plus Note (17.5% buffer; unlimited upside) and $1MM in the
Merck idea we had sent yesterday.
You free to discuss?
Paul
Paul Barrett I Managing Director I Global Investment Opportunities Group I ).P. Morgan Securities LLC I 3.P. Morgan Private
Bank I 3.P. Morgan Chase Bank N.A.
320 Park Avenue, 14th Floor, New York, NY 10022 I T:
F:
NOT AN OFFICIAL CONFIRMATION: For informational purposes only. This report does not represent an official account of the
holdings, balances, or transactions made in your account and is being provided at your request. Please refer to your monthly account
statement for the official record of all of your account activities. For question, please call your J.P. Morgan representative.
In discussion of options and other strategies, results and risks are based solely on hypothetical examples cited; actual results and risks
will vary depending on specific circumstances. Investors are urged to consider carefully whether option or option-related products in
general, as well as the products or strategies discussed herein are suitable to their needs. In actual transactions, the client's counterparty
for OTC derivatives applications is JPMorgan Chase Bank, N.A., and affiliates. For a copy of the "Characteristics and Risks of
Standardized Options" booklet, please contact your JPMorgan Advisor.
This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities,
accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at
httpliwww. an prgan.com/pages/disclosures/email.
EFTA00679914
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwj morgan.corn/pages/disclosures/email
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email and any files transmitted with it are confidential and intended solely for the person or entity to whom
they are addressed and may contain confidential and/or privileged material. Any review, retransmission,
dissemination or other use of, or taking of any action in reliance upon this information by persons or entities
other than the intended recipient is prohibited. If you have received this email in error please contact the sender
and delete the material from any computer. Apollo Global Management, LLC
EFTA00679915
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.